- Home
- Publications
- Publication Search
- Publication Details
Title
Designer drugs: a medicinal chemistry perspective (II)
Authors
Keywords
-
Journal
Annals of the New York Academy of Sciences
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-05-13
DOI
10.1111/nyas.14349
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Integrating tactics on opioids
- (2019) Alan I. Leshner SCIENCE
- Effects of the synthetic cannabinoid 5F-AMB on anxiety and recognition memory in mice
- (2019) Shiho Ito et al. PSYCHOPHARMACOLOGY
- Fatal intoxication with new synthetic cannabinoids AMB-FUBINACA and EMB-FUBINACA
- (2019) Piotr Adamowicz et al. CLINICAL TOXICOLOGY
- Fighting fire with fire: development of intranasal nalmefene to treat synthetic opioid overdose
- (2019) Philip Krieter et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Enantiospecific Synthesis, Chiral Separation, and Biological Activity of Four Indazole-3-Carboxamide-Type Synthetic Cannabinoid Receptor Agonists and Their Detection in Seized Drug Samples
- (2019) Lysbeth H. Antonides et al. Frontiers in Chemistry
- Toxic by design? Formation of thermal degradants and cyanide from carboxamide-type synthetic cannabinoids CUMYL-PICA, 5F-CUMYL-PICA, AMB-FUBINACA, MDMB-FUBINACA, NNEI, and MN-18 during exposure to high temperatures
- (2018) Richard C. Kevin et al. Forensic Toxicology
- Pharmacological evaluation of new constituents of “Spice”: synthetic cannabinoids based on indole, indazole, benzimidazole and carbazole scaffolds
- (2018) Clara T. Schoeder et al. Forensic Toxicology
- Monoamine Transporter and Receptor Interaction Profiles in Vitro Predict Reported Human Doses of Novel Psychoactive Stimulants and Psychedelics
- (2018) Dino Luethi et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Changes in Synthetic Opioid Involvement in Drug Overdose Deaths in the United States, 2010-2016
- (2018) Christopher M. Jones et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Metabolism of the synthetic cannabinoids AMB-CHMICA and 5C-AKB48 in pooled human hepatocytes and rat hepatocytes analyzed by UHPLC-(IMS)-HR-MS E
- (2018) Marie Mardal et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Haemorrhagic stroke related to the use of 4-fluoroamphetamine
- (2018) C. H. W. Wijers et al. JOURNAL OF NEUROLOGY
- Molecular and Behavioral Pharmacological Characterization of Abused Synthetic Cannabinoids MMB- and MDMB-FUBINACA, MN-18, NNEI, CUMYL-PICA, and 5-Fluoro-CUMYL-PICA
- (2018) Thomas F. Gamage et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Comparative neuropharmacology of N -(2-methoxybenzyl)-2,5-dimethoxyphenethylamine (NBOMe) hallucinogens and their 2C counterparts in male rats
- (2018) Joshua S. Elmore et al. NEUROPHARMACOLOGY
- The synthetic cannabinoid 5F-AMB changes the balance between excitation and inhibition of layer V pyramidal neurons in the mouse medial prefrontal cortex
- (2018) Masaki Domoto et al. PSYCHOPHARMACOLOGY
- Pharmacokinetic and pharmacodynamic evaluation of 5-methoxy-2-aminoindane (MEAI): A new binge-mitigating agent
- (2018) Jakob A. Shimshoni et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Pharmacotoxicology of Non-fentanyl Derived New Synthetic Opioids
- (2018) Renata Solimini et al. Frontiers in Pharmacology
- Khat (Catha edulis Forsk) – And now there are three
- (2018) Nilesh B. Patel BRAIN RESEARCH BULLETIN
- Application of an activity-based receptor bioassay to investigate the in vitro activity of selected indole- and indazole-3-carboxamide-based synthetic cannabinoids at CB1 and CB2 receptors
- (2018) Carolina Noble et al. Drug Testing and Analysis
- New psychoactive substances in Turkey: Narcotics cases assessed by the Council of Forensic Medicine between 2016 and 2017 in Ankara, Turkey
- (2018) Ersin Göl et al. FORENSIC SCIENCE INTERNATIONAL
- Synthetic cannabinoid hydroxypentyl metabolites retain efficacy at human cannabinoid receptors
- (2018) Thomas F Gamage et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Cannabinoid-like effects of five novel carboxamide synthetic cannabinoids
- (2018) Michael B. Gatch et al. NEUROTOXICOLOGY
- Identification of a new tert -leucinate class synthetic cannabinoid in powder and “spice-like” herbal incenses: Methyl 2-[[1-(5-fluoropentyl)indole-3-carbonyl]amino]-3,3-dimethyl-butanoate (5F-MDMB-PICA)
- (2017) Martijn D.P. Risseeuw et al. FORENSIC SCIENCE INTERNATIONAL
- Acute intoxication caused by synthetic cannabinoids 5F-ADB and MMB-2201: A case series
- (2017) Bernardino Barceló et al. FORENSIC SCIENCE INTERNATIONAL
- Underlying Factors in Drug Overdose Deaths
- (2017) Deborah Dowell et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2013–2016: A Review
- (2017) Barry K. Logan et al. JOURNAL OF ANALYTICAL TOXICOLOGY
- Development of a Clinically Viable Heroin Vaccine
- (2017) Paul T. Bremer et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Active vaccination attenuates the psychostimulant effects of α-PVP and MDPV in rats
- (2017) Jacques D. Nguyen et al. NEUROPHARMACOLOGY
- Opioid-Prescribing Patterns of Emergency Physicians and Risk of Long-Term Use
- (2017) Michael L. Barnett et al. NEW ENGLAND JOURNAL OF MEDICINE
- Addressing the Fentanyl Threat to Public Health
- (2017) Richard G. Frank et al. NEW ENGLAND JOURNAL OF MEDICINE
- “Zombie” Outbreak Caused by the Synthetic Cannabinoid AMB-FUBINACA in New York
- (2017) Axel J. Adams et al. NEW ENGLAND JOURNAL OF MEDICINE
- Δ9-Tetrahydrocannabinol-like discriminative stimulus effects of five novel synthetic cannabinoids in rats
- (2017) Michael B. Gatch et al. PSYCHOPHARMACOLOGY
- Drowning in diversity? A systematic way of clustering and selecting a representative set of new psychoactive substances
- (2017) Mire Zloh et al. RSC Advances
- Synthetic Aminoindanes: A Summary of Existing Knowledge
- (2017) Nikola Pinterova et al. Frontiers in Psychiatry
- Pharmacology of Valinate and tert-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their Analogues
- (2016) Samuel D. Banister et al. ACS Chemical Neuroscience
- Kappa opioid receptor antagonism and chronic antidepressant treatment have beneficial activities on social interactions and grooming deficits during heroin abstinence
- (2016) L. Lalanne et al. ADDICTION BIOLOGY
- Locomotor, discriminative stimulus, and place conditioning effects of MDAI in rodents
- (2016) Michael B. Gatch et al. BEHAVIOURAL PHARMACOLOGY
- Separation and structural characterization of the new synthetic cannabinoid JWH-018 cyclohexyl methyl derivative NE-CHMIMO using flash chromatography, GC-MS, IR and NMR spectroscopy
- (2016) Verena Angerer et al. FORENSIC SCIENCE INTERNATIONAL
- The 2-alkyl-2H-indazole regioisomers of synthetic cannabinoids AB-CHMINACA, AB-FUBINACA, AB-PINACA, and 5F-AB-PINACA are possible manufacturing impurities with cannabimimetic activities
- (2016) Mitchell Longworth et al. Forensic Toxicology
- Death Associated With the Use of the Synthetic Cannabinoid ADB-FUBINACA
- (2016) Kevin G. Shanks et al. JOURNAL OF ANALYTICAL TOXICOLOGY
- A new designer drug 5F-ADB activates midbrain dopaminergic neurons but not serotonergic neurons
- (2016) Nozomi Asaoka et al. JOURNAL OF TOXICOLOGICAL SCIENCES
- The Economic Burden of Prescription Opioid Overdose, Abuse, and Dependence in the United States, 2013
- (2016) Curtis S. Florence et al. MEDICAL CARE
- The new psychoactive substances 5-(2-aminopropyl)indole (5-IT) and 6-(2-aminopropyl)indole (6-IT) interact with monoamine transporters in brain tissue
- (2016) Julie A. Marusich et al. NEUROPHARMACOLOGY
- Emerging toxicity of 5,6-methylenedioxy-2-aminoindane (MDAI): Pharmacokinetics, behaviour, thermoregulation and LD50 in rats
- (2016) Tomáš Páleníček et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Metabolic profiling of new synthetic cannabinoids AMB and 5F-AMB by human hepatocyte and liver microsome incubations and high-resolution mass spectrometry
- (2016) Maria Andersson et al. RAPID COMMUNICATIONS IN MASS SPECTROMETRY
- Adverse Effects of Synthetic Cannabinoids: Management of Acute Toxicity and Withdrawal
- (2016) Ziva D. Cooper Current Psychiatry Reports
- Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA
- (2015) Samuel D. Banister et al. ACS Chemical Neuroscience
- Pharmacological profile of novel psychoactive benzofurans
- (2015) Anna Rickli et al. BRITISH JOURNAL OF PHARMACOLOGY
- An outbreak of acute delirium from exposure to the synthetic cannabinoid AB-CHMINACA
- (2015) Joseph A. Tyndall et al. CLINICAL TOXICOLOGY
- Prevalence of use and acute toxicity associated with the use of NBOMe drugs
- (2015) David M. Wood et al. CLINICAL TOXICOLOGY
- Recreational Use, Analysis and Toxicity of Tryptamines
- (2015) Roberta Tittarelli et al. Current Neuropharmacology
- Discriminative-stimulus effects of second generation synthetic cathinones in methamphetamine-trained rats
- (2015) Jennifer E. Naylor et al. DRUG AND ALCOHOL DEPENDENCE
- In vitroandin vivohuman metabolism of the synthetic cannabinoid AB-CHMINACA
- (2015) Claudio Erratico et al. Drug Testing and Analysis
- Death due to diabetic ketoacidosis: Induction by the consumption of synthetic cannabinoids?
- (2015) C. Hess et al. FORENSIC SCIENCE INTERNATIONAL
- A synthetic cannabinoid FDU-NNEI, two 2H-indazole isomers of synthetic cannabinoids AB-CHMINACA and NNEI indazole analog (MN-18), a phenethylamine derivative N–OH-EDMA, and a cathinone derivative dimethoxy-α-PHP, newly identified in illegal products
- (2015) Nahoko Uchiyama et al. Forensic Toxicology
- Urinary excretion and metabolism of the α-pyrrolidinophenone designer drug 1-phenyl-2-(pyrrolidin-1-yl)octan-1-one (PV9) in humans
- (2015) Noriaki Shima et al. Forensic Toxicology
- Molecular attributes of conjugate antigen influence function of antibodies induced by anti-nicotine vaccine in mice and non-human primates
- (2015) Michael J. McCluskie et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Combining Active Immunization with Monoclonal Antibody Therapy To Facilitate Early Initiation of a Long-Acting Anti-Methamphetamine Antibody Response
- (2015) Michael D. Hambuchen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synthetic Cannabinoid–Related Illnesses and Deaths
- (2015) Jordan Trecki et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification and quantitation of 5-fluoro-ADB, one of the most dangerous synthetic cannabinoids, in the stomach contents and solid tissues of a human cadaver and in some herbal products
- (2014) Koutaro Hasegawa et al. Forensic Toxicology
- Testing for Designer Stimulants: Metabolic Profiles of 16 Synthetic Cathinones Excreted Free in Human Urine
- (2014) Victor Uralets et al. JOURNAL OF ANALYTICAL TOXICOLOGY
- Locomotor stimulant and discriminative stimulus effects of ‘bath salt’ cathinones
- (2013) Michael B. Gatch et al. BEHAVIOURAL PHARMACOLOGY
- Recreational use of 1-(2-naphthyl)-2-(1-pyrrolidinyl)-1-pentanone hydrochloride (NRG-1), 6-(2-aminopropyl) benzofuran (Benzofury/ 6-APB) and NRG-2 with review of available evidence-based literature
- (2013) Jeshoor Jebadurai et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Emergence and properties of spice and bath salts: A medicinal chemistry perspective
- (2013) Anita H. Lewin et al. LIFE SCIENCES
- Nabilone Decreases Marijuana Withdrawal and a Laboratory Measure of Marijuana Relapse
- (2013) Margaret Haney et al. NEUROPSYCHOPHARMACOLOGY
- Behavioral and neurochemical pharmacology of six psychoactive substituted phenethylamines: mouse locomotion, rat drug discrimination and in vitro receptor and transporter binding and function
- (2013) Amy J. Eshleman et al. PSYCHOPHARMACOLOGY
- Vaccination protects rats from methamphetamine-induced impairment of behavioral responding for food
- (2013) Daniela Rüedi-Bettschen et al. VACCINE
- Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity
- (2012) Lisa K. Brents et al. BIOCHEMICAL PHARMACOLOGY
- Discriminative stimulus effects of N,N-diisopropyltryptamine
- (2012) Theresa M Carbonaro et al. PSYCHOPHARMACOLOGY
- Co-administration of morphine and oxycodone vaccines reduces the distribution of 6-monoacetylmorphine and oxycodone to brain in rats
- (2012) M. Pravetoni et al. VACCINE
- Designer drugs: a medicinal chemistry perspective
- (2011) F. Ivy Carroll et al. Annals of the New York Academy of Sciences
- Synthesis of Mercapto-(+)-methamphetamine Haptens and Their Use for Obtaining Improved Epitope Density on (+)-Methamphetamine Conjugate Vaccines
- (2011) F. Ivy Carroll et al. JOURNAL OF MEDICINAL CHEMISTRY
- In Vivo Effects of Amphetamine Analogs Reveal Evidence for Serotonergic Inhibition of Mesolimbic Dopamine Transmission in the Rat
- (2011) M. H. Baumann et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- 5-Methoxy-N,N-di(iso)propyltryptamine hydrochloride (Foxy)-induced cognitive deficits in rat after exposure in adolescence
- (2011) David M. Compton et al. PHYSIOLOGY & BEHAVIOR
- Phase I Hydroxylated Metabolites of the K2 Synthetic Cannabinoid JWH-018 Retain In Vitro and In Vivo Cannabinoid 1 Receptor Affinity and Activity
- (2011) Lisa K. Brents et al. PLoS One
- Comparison of the developmental effects of 5-methoxy-N,N-diisopropyltryptamine (Foxy) to (±)-3,4-methylenedioxymethamphetamine (ecstasy) in rats
- (2009) Matthew R. Skelton et al. PSYCHOPHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started